These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24401336)

  • 41. Challenges in antimicrobial drug discovery and the potential of nucleoside antibiotics.
    Rachakonda S; Cartee L
    Curr Med Chem; 2004 Mar; 11(6):775-93. PubMed ID: 15032731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meeting report: Third Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS).
    Le Grice SF; Sztuba-Solinska J; Maccioni E; Purzycka KJ; Parolin C; Tramontano E
    Antiviral Res; 2017 Mar; 139():13-17. PubMed ID: 27939841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interscience Conference on Antimicrobial Agents and Chemotherapy - 50th Annual Meeting - Research on Promising New Agents: Part 1.
    Walker K
    IDrugs; 2010 Nov; 13(11):743-5. PubMed ID: 21046515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frontiers in Medicinal Chemistry 2015: Meet the Experts of MedChem near the Cradle of Medicinal and Pharmaceutical Chemistry.
    Wegscheid-Gerlach C; Gerber HD; Diederich WE
    ChemMedChem; 2015 Jul; 10(7):1267-71. PubMed ID: 26038282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Broken drug markets in infectious diseases: Opportunities outside the private sector?
    Alpern JD; Dunlop SJ; Stauffer WM
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007190. PubMed ID: 30973876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Highlights from the 13th European Congress of Clinical Microbiology and Infectious Diseases in Glasgow, Scotland, May 10-13, 2003. The complex world of infectious diseases.
    Jack D
    Drug News Perspect; 2003; 16(6):399-401. PubMed ID: 12973451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perspectives into the diversity of the U.K. pharmaceutical industry.
    Society for Medicines Research Committee
    Drug News Perspect; 2003 Mar; 16(2):125-8. PubMed ID: 12792673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Australian Society of Antimicrobials--tenth annual scientific meeting. 26-28 February 2009, Melbourne, Australia.
    Coombs G
    IDrugs; 2009 Apr; 12(4):201-3. PubMed ID: 19350457
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibiotic development pipeline runs dry. New drugs to fight resistant organisms are not being developed, experts say.
    Nelson R
    Lancet; 2003 Nov; 362(9397):1726-7. PubMed ID: 14655659
    [No Abstract]   [Full Text] [Related]  

  • 50. Medicinal Chemistry - XXIst International Symposium.
    Chan D
    IDrugs; 2010 Nov; 13(11):749-52. PubMed ID: 21046517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural products in drug discovery: present status and perspectives.
    Molinari G
    Adv Exp Med Biol; 2009; 655():13-27. PubMed ID: 20047031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Making space for anti-infective drug discovery.
    Nathan C
    Cell Host Microbe; 2011 May; 9(5):343-8. PubMed ID: 21575903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug resistance: a growing problem.
    Peet NP
    Drug Discov Today; 2010 Aug; 15(15-16):583-6. PubMed ID: 20434584
    [No Abstract]   [Full Text] [Related]  

  • 54. New developments in antiinfectives research for tropical infectious diseases.
    Chibale K
    Bioorg Med Chem; 2015 Aug; 23(16):5085-6. PubMed ID: 26014483
    [No Abstract]   [Full Text] [Related]  

  • 55. Anti-infective carbonic anhydrase inhibitors: a patent and literature review.
    Capasso C; Supuran CT
    Expert Opin Ther Pat; 2013; 23(6):693-704. PubMed ID: 23488877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.
    Gonzalez D; Schmidt S; Derendorf H
    Clin Microbiol Rev; 2013 Apr; 26(2):274-88. PubMed ID: 23554417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Infectious diseases--new horizons].
    Spirer Z; Barzilai A
    Harefuah; 2012 Aug; 151(8):483-7, 496. PubMed ID: 23350296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can we help one billion sick people?
    Maliski E; Gund P; Brown F
    Curr Opin Drug Discov Devel; 2008 May; 11(3):301-2. PubMed ID: 18428082
    [No Abstract]   [Full Text] [Related]  

  • 60. Counter resistance.
    Nat Microbiol; 2017 Apr; 2():17071. PubMed ID: 28440290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.